Add to ORKGThis home-study CPE activity has been developed to educate pharmacists on updates in anti-platelet therapy after stent implantation
Platelets play a central role in the atherosclerotic inflammatory response, thrombotic vascular occl...
BACKGROUND: Guidelines recommend P2Y12 inhibitor therapy for 1 year after myocardial infarction (MI)...
The goal of antiplatelet therapy for patients with acute coronary syndromes undergoing percutaneous ...
This home-study CPE activity has been developed to educate pharmacists on updates in anti-platelet t...
Numerous clinical trials have established the value of antiplatelet therapies for acute coronary syn...
© 2020 Thieme Publishing Group. This is an accepted manuscript of an article accepted for publicatio...
Because platelet activation plays an important pathophysiological role in acute coronary syndromes, ...
Acetylsalicylic acid remains the basis of anti-platelet therapy for stable ischemic heart disease (I...
© 2014 Bentham Science Publishers.Antiplatelet therapy plays an important role in the treatment of p...
Dual antiplatelet therapy (DAT) has become standard care for patients undergoing percutaneous corona...
Background: Prasugrel and ticagrelor are two novel antiplatelet agents, which have been subject to l...
Platelet activation and subsequent aggregation play a dominant role in the propagation of arterial t...
Recent clinical data show that the risk of coronary thrombosis after antiplatelet drugs withdrawal i...
Objective: To review available evidence and examine issues surrounding the use of advanced antiplate...
Contains fulltext : 169887.pdf (publisher's version ) (Closed access)Antithromboti...
Platelets play a central role in the atherosclerotic inflammatory response, thrombotic vascular occl...
BACKGROUND: Guidelines recommend P2Y12 inhibitor therapy for 1 year after myocardial infarction (MI)...
The goal of antiplatelet therapy for patients with acute coronary syndromes undergoing percutaneous ...
This home-study CPE activity has been developed to educate pharmacists on updates in anti-platelet t...
Numerous clinical trials have established the value of antiplatelet therapies for acute coronary syn...
© 2020 Thieme Publishing Group. This is an accepted manuscript of an article accepted for publicatio...
Because platelet activation plays an important pathophysiological role in acute coronary syndromes, ...
Acetylsalicylic acid remains the basis of anti-platelet therapy for stable ischemic heart disease (I...
© 2014 Bentham Science Publishers.Antiplatelet therapy plays an important role in the treatment of p...
Dual antiplatelet therapy (DAT) has become standard care for patients undergoing percutaneous corona...
Background: Prasugrel and ticagrelor are two novel antiplatelet agents, which have been subject to l...
Platelet activation and subsequent aggregation play a dominant role in the propagation of arterial t...
Recent clinical data show that the risk of coronary thrombosis after antiplatelet drugs withdrawal i...
Objective: To review available evidence and examine issues surrounding the use of advanced antiplate...
Contains fulltext : 169887.pdf (publisher's version ) (Closed access)Antithromboti...
Platelets play a central role in the atherosclerotic inflammatory response, thrombotic vascular occl...
BACKGROUND: Guidelines recommend P2Y12 inhibitor therapy for 1 year after myocardial infarction (MI)...
The goal of antiplatelet therapy for patients with acute coronary syndromes undergoing percutaneous ...